SCHEMBL18909449

SCHEMBL18909449

CCC(=O)N1CCC(CN2CCN(C(C)=O)CC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 2/20 0.45
CACNA1B Q00975 2/20 0.45
CACNB1 Q02641 2/20 0.45
CACNA1C Q13936 1/20 0.45
PIK3CD O00329 1/20 0.42
EPHX2 P34913 3/20 0.42
CXCR3 P49682 1/20 0.41
HSD11B1 P28845 1/20 0.41
EPHX1 P07099 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 2/20 0.39
SIGMAR1 Q99720 1/20 0.38
CNR1 P21554 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20471042 0.88 HRH3 (0.48) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL24521471 0.86 HSD11B1 (0.47) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL25701777 0.85 HSD11B1 (0.53) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL18389996 0.85 HSD11B1 (0.45) CACNA2D1CACNA1BCACNB1CACNA1CPIK3CD
SCHEMBL12507042 0.85 MAPT (0.49) EPHX2MAPT
SCHEMBL18909448 0.84 CACNA2D1 (0.43) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL4550243 0.84 PIK3CD (0.52) CACNA2D1CACNA1BCACNB1CACNA1CPIK3CD
SCHEMBL18909455 0.83 PKM (0.43) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL22030478 0.83 CNR1 (0.43) CACNA2D1CACNA1BCACNB1CACNA1CPIK3CD
SCHEMBL18909445 0.83 CACNA2D1 (0.42) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed